Protein kinase inhibitors in the management of clear cell renal cell carcinoma metastatic to the iris-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protein kinase inhibitors in the management of clear cell renal cell carcinoma metastatic to the iris

Published:2023-12 Issue:10 Volume:46 Page:e365-e367
ISSN:0181-5512
Container-title:Journal Français d'Ophtalmologie
language:en
Short-container-title:Journal Français d'Ophtalmologie

Author:

Koç I.,Kiratli H.^ORCID,Kapucu Y.^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference11 articles.

1. Epidemiology of renal cell carcinoma;Padala;World J Oncol,2020

2. Primary tumor type, clinical features, treatment and outcome of patients with iris metastasis;Liu;Ocular Immunol Inflamm,2022

3. Targeting angiogenesis in metastatic renal cell carcinoma;Canino;Expert Rev Anticancer Ther,2019

4. Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice;Roberto;Front Oncol,2021

5. Systemic treatment of metastatic renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions;Lalani;Eur Urol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP